Craig C. Hopkinson - Feb 22, 2024 Form 4 Insider Report for Alkermes plc. (ALKS)

Role
EVP R&D, Chief Medical Officer
Signature
/s/ Jeffrey Geary, attorney-in-fact for Craig C. Hopkinson
Stock symbol
ALKS
Transactions as of
Feb 22, 2024
Transactions value $
-$157,617
Form type
4
Date filed
2/23/2024, 04:07 PM
Previous filing
Feb 21, 2024
Next filing
Feb 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALKS Ordinary Shares Options Exercise +12.3K +12.45% 111K Feb 22, 2024 Direct F1
transaction ALKS Ordinary Shares Tax liability -$158K -5.45K -4.92% $28.91 105K Feb 22, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALKS Restricted Stock Unit Award Options Exercise -12.3K -50% 12.3K Feb 22, 2024 Ordinary Shares 12.3K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one ordinary share.
F2 Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/22/2022.